Professional Documents
Culture Documents
GCF (Gynecologic Cancer Foundation) Presentation
GCF (Gynecologic Cancer Foundation) Presentation
org
GCF (Gynecologic Cancer Foundation) Presentation
www.maketheconnection.org
www.cancer.org
1/Wright/p.21
20/abstract
conclusions
2/Bonnez/p.
576/Figure
12; p. 578/col
1/¶2
3/CCS/p 6/¶2
4/Sellors/Ch.
7/p.9/Figure
7.23.
1. Wright TC Jr, Cox JT, Massad LS, et al, for the ASCCP-Sponsored
Consensus Congress. JAMA. 2002;287:2120–2129. 2. Bonnez W. In:
Richman DD, Whitley RJ, Hayden FJ, eds. Washington, DC: American
Society for Microbiology Press; 2002:557–596. 3. Canadian Cancer
Society. Cervical Cancer: What you need to know. Available at:
1/Sellors/Ch http://www.cancer.ca/vgn/images/portal/cit_86751114/63/40/151140772cw
. 4/p. 1/¶ 1; _library_wyntk_cervical_en.pdf. Accessed March 13, 2006. 4. Reprinted
p.5/¶ 2 with permission from Sellors JW, Sankaranarayanan R, eds. Colposcopy
and Treatment of Cervical Intraepithelial Neoplasia. A Beginner’s Manual.
1/Sellors/Ch
. 7/p. 1/¶ 1; Lyon, France: International Agency for Research on Cancer; 2003.
p. 6/¶ 3,
Figure 7.12.
1/Sellors/Ch.
www.maketheconnection.org
www.cdc.gov/std/HPV/STDFcat-HPV.htm
1/Parham/p.
S14/Table 1.
2/Schink/p. 5/
col 2/¶2.
3/Uyar/p. 227/
abstract.
4/Kulasingam/p.
1754/Table 3.
2/Schink/p.
5/col 2/¶1.
5/Selvaggi/
p. 1506/col
1/¶1, 3.
6/Chacho/p.
137/col 2/¶5
1/Hewitt/p.
1. Hewitt M, Devesa SS, Breen N. Cervical cancer screening among U.S. women: analyses of the
270/ col 1/¶1 2000 National Health Interview Survey. Prev Med. 2004;39:270-278.
2. Crum CP, Rivera MN. Vaccines for cervical cancer. Cancer J. 2003;9:368–376.
3. Sung HY, Kearney KA, Miller M, Kinney W, Sawaya GF, Hiatt RA. Papanicolaou smear history
and diagnosis of invasive cervical carcinoma among members of a large prepaid health plan.
2/Crum/p. Cancer. 2000;88:2283–2289.
368/col 1/¶2; 4. Schink JC. Strategies for detecting cervical dysplasia: Visual inspection, spectroscopy, and
col 2/¶1 speculoscopy. OBG Manag. 2003;(suppl):5–8.
5. Selvaggi SM. Implications of low diagnostic reproducibility of cervical cytologic and histologic
diagnoses. JAMA. 2001;285:1506–1508.
3/Sung/p. 6. Chacho MS, Mattie ME, Schwartz PE. Cytohistologic correlation rates between conventional
2285/col Papanicolaou smears and ThinPrep cervical cytology: A comparison. Cancer. 2003;99:135–140.
2/¶3, 4 7. Saslow D, Runowicz CD, Solomon D, et al. American Cancer Society Guideline for the early
detection of cervical neoplasia and cancer. CA Cancer J Clin. 2002;52:342–362.
8. Uyar DS, Eltabbakh GH, Mount SL. Positive predictive value of liquid-based and conventional
4/Schink/ p. cervical Papanicolaou smears reported as malignant. Gynecol Oncol. 2003;89:227–232.
5/ col 2/¶1. 9. Kulasingam SL, Hughes JP, Kiviat NB, et al. Evaluation of human papillomavirus testing in
primary screening for cervical abnormalities: Comparison of sensitivity, specificity, and frequency of
5/Selvaggi/ referral. JAMA. 2002;288:1749–1757.
p. 1506/col
1/¶1, 3.
6/Chacho/ p.
137/col 2/¶5
5/Selvaggi/
p. 1506/col
American Cancer Detailed Guide. American Cancer Society Online
Publication. http://www.cancer.org
The picture on your left is the magnified image of a
normal cervix after the application of Acetic acid.